Literature DB >> 29126815

Analysis of Suicide Risk in Patients with Penile Cancer and Review of the Literature.

William G Simpson1, Zachary Klaassen2, Rita P Jen3, William M Hughes4, Durwood E Neal4, Martha K Terris4.   

Abstract

The treatment for penile cancer has been shown to cause harmful psychiatric symptoms as well as have detrimental effects on well-being. In the past several years, alternatives to total or partial penectomy have emerged, such as chemotherapy, radiation, penile sparing, and laser ablation therapies. A more specific breakdown for penile cancer is in order as the therapy has the potential for life changing surgery. We examined the Surveillance, Epidemiology, and End Results (SEER) database (1973-2013), comprising 28% of the United States population. International Classification of Diseases, Tenth revision codes C60.8-C60.9 and the International Classification of Diseases-Oncology codes 8010/2, 8010/3, 8051/2, 8051/3, 8052/2, 8052/3, 8070/2, 8070/3-8072/3, 8074/3, 8076/3, and 8083/3-8084/3 were used. Age, race, marital status, and clinicopathologic variables were studied. We used contingency tables of suicide rates; mid-P exact test was used for analysis. There were 13 suicides noted in 6155 patients with squamous cell carcinoma of the penis. All patients that committed suicide had undergone a surgical intervention. Certainly, penile cancer after treatment has a powerful effect on quality of life as increased depression and sexual anxiety have been documented in postoperative patients. This is in contrast to the observed suicide rate. Despite the reported negative psychological effects in patients with penile cancer, suicide rates are among the lowest of all urologic malignancies. Published by Elsevier Inc.

Entities:  

Keywords:  Depression; Malignacy; Penectomy; Penile-sparing; Psychiatric

Mesh:

Year:  2017        PMID: 29126815     DOI: 10.1016/j.clgc.2017.09.011

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  7 in total

1.  [Psychosocial effects in patients with penile cancer : A systematic review].

Authors:  D L Dräger; S Milerski; K D Sievert; O W Hakenberg
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

2.  Suicide among cancer patients: adolescents and young adult (AYA) versus all-age patients.

Authors:  Huaqiang Zhou; Wei Xian; Yaxiong Zhang; Yunpeng Yang; Wenfeng Fang; Jiaqing Liu; Jiayi Shen; Zhonghan Zhang; Shaodong Hong; Yan Huang; Li Zhang
Journal:  Ann Transl Med       Date:  2019-11

3.  Large verrucous penis cancer in a young patient in the Brazilian Amazon: Case report and discussion on the region's reality.

Authors:  Francisco Marcos da Silva Barroso; Cristiano Silveira Paiva; Flavio Antunes de Sousa; Gualter Ferreira de Andrade Júnior; Roger Arthur da Cunha Alves; Ketlen Gomes da Costa; Rafaelle Taynah Soares da Silva; Juan Eduardo Rios Rodriguez; Evandro Aulice de Peder Júnior
Journal:  Urol Case Rep       Date:  2019-02-22

4.  Risk factors associated with suicide among kidney cancer patients: A Surveillance, Epidemiology, and End Results analysis.

Authors:  Chenyu Guo; Wenwen Zheng; Weiwei Zhu; Shengqiang Yu; Yuexia Ding; Qingna Wu; Qiling Tang; Congxiao Lu
Journal:  Cancer Med       Date:  2019-07-11       Impact factor: 4.452

Review 5.  The role of penectomy in penile cancer-evolving paradigms.

Authors:  Sarah O'Neill; Mitchell Barns; Filip Vujovic; Mikhail Lozinskiy
Journal:  Transl Androl Urol       Date:  2020-12

6.  Risk factors associated with suicide among esophageal carcinoma patients from 1975 to 2016.

Authors:  Chongfa Chen; Huapeng Lin; Fengfeng Xu; Jianyong Liu; Qiucheng Cai; Fang Yang; Lizhi Lv; Yi Jiang
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

7.  Analysis of suicide risk in adult US patients with squamous cell carcinoma: a retrospective study based on the Surveillance, Epidemiology and End Results database.

Authors:  Haohui Yu; Shengru Tao; Wenli She; Min Liu; Yayun Wu; Jun Lyu
Journal:  BMJ Open       Date:  2022-09-15       Impact factor: 3.006

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.